4//SEC Filing
Hung David 4
Accession 0001209191-23-014890
CIK 0001811063other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:01 PM ET
Size
7.6 KB
Accession
0001209191-23-014890
Insider Transaction Report
Form 4
Hung David
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-02-28+2,500,000→ 2,500,000 totalExercise: $1.94Exp: 2033-02-27→ Class A Common Stock (2,500,000 underlying) - Other
Class A Common Stock
2021-03-02−368,408→ 58,281,054 total
Footnotes (3)
- [F1]On March 2, 2021, the Reporting Person surrendered 368,408 shares of the Issuer's Class A Common Stock in connection with the satisfaction of the Issuer's obligations to GiraFpharma LLC.
- [F2]Includes 2,661 shares acquired on May 19, 2022 and 1 share acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
- [F3]Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Documents
Issuer
Nuvation Bio Inc.
CIK 0001811063
Entity typeother
Related Parties
1- filerCIK 0001310880
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:01 PM ET
- Size
- 7.6 KB